OCULIS EHF has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals, micro-structure and nano-technology and machines are VEREX LAB, LEKO VLADIMIR and DONG GUIYU.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Argentina | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Taiwan | 2 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Canada | 1 | |
#10 | Colombia | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 | |
#14 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Micro-structure and nano-technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Nanostructure applications | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Loftsson Thorsteinn | 21 |
#2 | Fulop Zoltan | 5 |
#3 | Stefansson Einar | 4 |
#4 | Flp Zoltn | 2 |
#5 | Thorsteinn Loftsson | 2 |
Publication | Filing date | Title |
---|---|---|
CN110177576A | The preparation of solid cyclodextrin complexes for the delivering of ophthalmically acceptable active pharmaceutical ingredient | |
KR20180028992A | Formation of Cyclosporin A / Cyclodextrin Nanoparticles | |
US2007020336A1 | Cyclodextrin nanotechnology for ophthalmic drug delivery |